Michael Percival, University of British Columbia

Research

Arthritis Bone Cancer Cathepsin K Collagen Dose Response Drug Development Ectosteric Inhibitors Protease

Latest funding

Side effect-free cathepsin K targeting drugs for skeletal diseases
CIHR · 2017 · Principal investigator
$359,850

Side effect-free cathepsin K targeting drugs for skeletal diseases

Principal investigatorCIHR2017Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Bromme, Dieter; Percival, Michael D; Ciufolini, Marco A

Keywords: Arthritis; Bone Cancer; Cathepsin K; Collagen; Dose Response; Drug Development; Ectosteric Inhibitors; Protease; Protease Inhibitors; Tanshinones

$359,850

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Arthritis Dear Professor Percival, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on arthritis connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]